Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

CLIA - Clinical Laboratory Improvement Amendments
  • Print
  • Share
  • E-mail
-
1 to 4 of 4 Results
Document Number K253839
Results per Page

New Searchexport reports to excelExport to Excel | HelpHelp
Document Parent Analyte Analyte Specialty Complexity Effective Date
Roche Diagnostics, cobas e 801 Analyzer  {Elecsys Anti-SARS-CoV-2} 
CR260007 K253839 SARS-CoV-2 antibodies General Immunology MODERATE 02/02/2026
Roche Diagnostics, cobas e 402 Analyzer  {Elecsys Anti-SARS-CoV-2} 
CR260007 K253839 SARS-CoV-2 antibodies General Immunology MODERATE 02/02/2026
Roche Diagnostics, cobas e 411 Analyzer  {Elecsys Anti-SARS-CoV-2} 
CR260007 K253839 SARS-CoV-2 antibodies General Immunology MODERATE 02/02/2026
Roche Diagnostics, cobas e 602 Analyzer  {Elecsys Anti-SARS-CoV-2} 
CR260007 K253839 SARS-CoV-2 antibodies General Immunology MODERATE 02/02/2026

-
-